QA: Calithera Biosciences Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001496671_2023_Calithera_Biosciences_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001496671, Calithera Biosciences Inc

  xvar xval
0 AssetsCurrent 26,624,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 434,000
3 remainder_Assets 1,618,000
4 LiabilitiesCurrent 7,390,000
5 LiabilitiesNoncurrent 136,000
6 remainder_Liabilities 758,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,016,105
9 ResearchAndDevelopmentExpense -44,289,869
10 remainder_Expenses 49,929,733
11 remainder_Revenues 783,012
12 remainder_NetIncome 2,282,297
13 remainder_ComprehensiveNetIncome -1,139
  yvar yval
0 Assets 28,676,000
1 Liabilities 8,284,000
2 Expenses 9,655,969
3 Revenues 783,012
4 StockholdersEquity 20,392,000
5 NetIncome -6,590,660
6 ComprehensiveNetIncome -6,591,230
7 BaseVar 24,841,208
8 EconomicCapitalRatiobeforeLimitedLiability 2.05
9 EconomicCapitalRatio 3.06

Edgar->Model Mapping

Feature Distribution

Change over Time